• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

更健康的KL-VS杂合子具有更有利的与阿尔茨海默病相关的生物标志物特征。

More fit KL-VS heterozygotes have more favorable AD-relevant biomarker profiles.

作者信息

Jarchow Mackenzie, Driscoll Ira, Breidenbach Brianne M, Cook Noah, Gallagher Catherine L, Johnson Sterling C, Asthana Sanjay, Hermann Bruce P, Sager Mark A, Blennow Kaj, Zetterberg Henrik, Carlsson Cynthia M, Kollmorgen Gwendlyn, Quijano-Rubio Clara, Cook Dane B, Dubal Dena B, Okonkwo Ozioma C

机构信息

Wisconsin Alzheimer's Disease Research Center Department of Medicine School of Medicine and Public Health University of Wisconsin-Madison Madison Wisconsin USA.

Wisconsin Alzheimer's Institute Madison Wisconsin USA.

出版信息

Alzheimers Dement (N Y). 2025 Aug 8;11(3):e70133. doi: 10.1002/trc2.70133. eCollection 2025 Jul-Sep.

DOI:10.1002/trc2.70133
PMID:
40787159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12333875/
Abstract

INTRODUCTION

Although hallmarked by β-amyloid plaques (Aβ) and neurofibrillary tangles (tau), Alzheimer's disease (AD) is a multifactorial disorder that involves neuroinflammation, neurodegeneration, and synaptic dysfunction. AD-associated biomolecular changes seem to be attenuated in carriers of the functionally advantageous variant of the gene (KL-VS). Independently, better cardiorespiratory fitness (CRF) is associated with better health outcomes related to AD pathology. Here we investigate whether the relationships between CRF (peak oxygen consumption (VO)) and cerebrospinal fluid (CSF) core AD biomarkers and those of neuroinflammation, neurodegeneration, and synaptic dysfunction differ for KL-VS compared to noncarriers (KL-VS).

METHODS

The cohort, enriched for AD risk, consisted of cognitively unimpaired adults ( = 136; Mean(SD) = 62.5(6.7)) from the Wisconsin Registry for Alzheimer's Prevention and the Wisconsin Alzheimer's Disease Research Center. Covariate-adjusted (age, sex, parental AD history, apolipoprotein E ( 4+ status, and age difference between CSF sampling and exercise test) linear models examined the interaction between VO and genotype on CSF core AD biomarker levels (phosphorylated tau 181 [pTau], Aβ/Aβ, pTau/Aβ). Analyses were repeated for CSF biomarkers of neurodegeneration (total tau [tTau], α-synuclein [α-syn], neurofilament light polypeptide [NfL]), synaptic dysfunction (neurogranin [Ng]), and neuroinflammation (glial fibrillary acidic protein [GFAP], soluble triggering receptor expressed in myeloid cells [sTREM2], chitinase-3-like protein 1 [YKL-40], interleukin 6 [IL-6], S100 calcium-binding protein B [S100B]).

RESULTS

The interaction between VO and KL-VS was significant for tTau ( = 0.05), pTau ( = 0.03), Ng ( = 0.02), sTREM2 ( = 0.03), and YKL-40 ( = 0.03), such that lower levels of each biomarker were observed for KL-VS who were more fit. No significant KL-VSxVO interactions were observed for Aβ/Aβ, pTau/Aβ, α-syn, NfL, GFAP, IL-6 or S100B (all s>0.09).

CONCLUSIONS

We report a synergistic relationship between KL-VS and CRF with pTau, tTau, Ng, sTREM2 and YKL-40, suggesting a protective role for both KL-VS and better CRF against unfavorable AD-related changes. Their potentially shared biological mechanisms require future investigations.

HIGHLIGHTS

KL-VS and higher cardiorespiratory fitness (CRF) may protect against unfavorable Alzheimer's disease (AD)-related changes.Higher CRF attenuates neurodegeneration and synaptic dysfunction in KL-VS.More fit KL-VS also has lower levels of pTau and less neuroinflammation.

摘要

引言

尽管阿尔茨海默病(AD)以β-淀粉样蛋白斑块(Aβ)和神经原纤维缠结(tau)为特征,但它是一种多因素疾病,涉及神经炎症、神经退行性变和突触功能障碍。AD相关的生物分子变化在基因(KL-VS)功能优势变体的携带者中似乎有所减弱。另外,更好的心肺适能(CRF)与AD病理学相关的更好健康结果有关。在此,我们研究与非携带者(KL-VS)相比,KL-VS的CRF(峰值耗氧量(VO))与脑脊液(CSF)核心AD生物标志物之间以及神经炎症、神经退行性变和突触功能障碍之间的关系是否存在差异。

方法

该队列富含AD风险因素,由来自威斯康星州阿尔茨海默病预防登记处和威斯康星州阿尔茨海默病研究中心的认知未受损成年人(n = 136;平均(标准差)= 62.5(6.7))组成。经协变量调整(年龄、性别、父母AD病史、载脂蛋白E(ε4+状态以及CSF采样与运动测试之间的年龄差异)的线性模型检验了VO与基因型对CSF核心AD生物标志物水平(磷酸化tau 181 [pTau]、Aβ42/Aβ40、pTau/Aβ42)的相互作用。对神经退行性变(总tau [tTau]、α-突触核蛋白[α-syn]、神经丝轻链多肽[NfL])、突触功能障碍(神经颗粒素[Ng])和神经炎症(胶质纤维酸性蛋白[GFAP]、髓样细胞中表达的可溶性触发受体[sTREM2]、几丁质酶-3样蛋白1 [YKL-40]、白细胞介素6 [IL-6]、S100钙结合蛋白B [S100B])的CSF生物标志物重复进行分析。

结果

VO与KL-VS之间的相互作用在tTau(p = 0.05)、pTau(p = 0.03)、Ng(p = 0.02)、sTREM2(p = 0.03)和YKL-40(p = 0.03)方面具有显著性,因此对于身体更健康的KL-VS携带者,观察到每种生物标志物的水平较低。在Aβ42/Aβ40、pTau/Aβ42、α-syn、NfL、GFAP、IL-6或S100B方面未观察到显著的KL-VS×VO相互作用(所有p>0.09)。

结论

我们报告了KL-VS与CRF在pTau、tTau、Ng、sTREM2和YKL-40方面存在协同关系,表明KL-VS和更好的CRF对不利的AD相关变化均具有保护作用。它们潜在的共同生物学机制需要未来进一步研究。

要点

KL-VS和更高的心肺适能(CRF)可能预防不利的阿尔茨海默病(AD)相关变化。更高的CRF可减轻KL-VS中的神经退行性变和突触功能障碍。身体更健康的KL-VS携带者的pTau水平也较低且神经炎症较少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f7c/12333875/58486fb3dc6e/TRC2-11-e70133-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f7c/12333875/a8c7c3ad3f6a/TRC2-11-e70133-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f7c/12333875/58486fb3dc6e/TRC2-11-e70133-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f7c/12333875/a8c7c3ad3f6a/TRC2-11-e70133-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f7c/12333875/58486fb3dc6e/TRC2-11-e70133-g001.jpg

相似文献

1
More fit KL-VS heterozygotes have more favorable AD-relevant biomarker profiles.更健康的KL-VS杂合子具有更有利的与阿尔茨海默病相关的生物标志物特征。
Alzheimers Dement (N Y). 2025 Aug 8;11(3):e70133. doi: 10.1002/trc2.70133. eCollection 2025 Jul-Sep.
2
Older more fit KL-VS heterozygotes have more favorable AD-relevant biomarker profiles.年龄较大但身体更健康的KL-VS杂合子具有更有利的与阿尔茨海默病相关的生物标志物特征。
medRxiv. 2025 Mar 3:2025.02.27.25323056. doi: 10.1101/2025.02.27.25323056.
3
KLOTHO KL-VS heterozygosity is associated with diminished age-related neuroinflammation, neurodegeneration, and synaptic dysfunction in older cognitively unimpaired adults.KLOTHO KL-VS 杂合性与老年认知正常成年人年龄相关的神经炎症、神经退行性变和突触功能障碍的减少有关。
Alzheimers Dement. 2024 Aug;20(8):5347-5356. doi: 10.1002/alz.13912. Epub 2024 Jun 21.
4
Associations of KLOTHO-VS heterozygosity and α-Klotho protein with cerebrospinal fluid Alzheimer's disease biomarkers.KLOTHO-VS杂合性和α-klotho蛋白与脑脊液阿尔茨海默病生物标志物的关联。
J Alzheimers Dis. 2025 May;105(1):159-171. doi: 10.1177/13872877251326199. Epub 2025 Mar 20.
5
The impact of kidney function on Alzheimer's disease blood biomarkers: implications for predicting amyloid-β positivity.肾功能对阿尔茨海默病血液生物标志物的影响:对预测淀粉样蛋白-β阳性的意义。
Alzheimers Res Ther. 2025 Feb 19;17(1):48. doi: 10.1186/s13195-025-01692-z.
6
Early microglial and astrocyte reactivity in preclinical Alzheimer's disease.临床前阿尔茨海默病中早期小胶质细胞和星形胶质细胞反应性
Alzheimers Dement. 2025 Aug;21(8):e70502. doi: 10.1002/alz.70502.
7
Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer's disease.数据驱动的脑脊液生物标志物分析:阿尔茨海默病风险队列中的影像学和临床结果
Alzheimers Res Ther. 2024 Dec 23;16(1):274. doi: 10.1186/s13195-024-01629-y.
8
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.脑脊液和血液生物标志物在阿尔茨海默病诊断中的应用:系统评价和荟萃分析。
Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8.
9
The ratio of plasma pTau217 to Aβ42 outperforms individual measurements in detecting brain amyloidosis.在检测脑淀粉样变性方面,血浆pTau217与Aβ42的比值比单独测量更具优势。
medRxiv. 2025 Jan 10:2024.12.07.24318640. doi: 10.1101/2024.12.07.24318640.
10
Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.几丁质酶-3样1蛋白(CHI3L1)基因座影响YKL-40的脑脊液水平。
BMC Neurol. 2016 Nov 10;16(1):217. doi: 10.1186/s12883-016-0742-9.

本文引用的文献

1
KLOTHO KL-VS heterozygosity is associated with diminished age-related neuroinflammation, neurodegeneration, and synaptic dysfunction in older cognitively unimpaired adults.KLOTHO KL-VS 杂合性与老年认知正常成年人年龄相关的神经炎症、神经退行性变和突触功能障碍的减少有关。
Alzheimers Dement. 2024 Aug;20(8):5347-5356. doi: 10.1002/alz.13912. Epub 2024 Jun 21.
2
2024 Alzheimer's disease facts and figures.2024 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2024 May;20(5):3708-3821. doi: 10.1002/alz.13809. Epub 2024 Apr 30.
3
Effect of exercise engagement and cardiovascular risk on neuronal injury.
运动参与和心血管风险对神经元损伤的影响。
Alzheimers Dement. 2023 Oct;19(10):4454-4462. doi: 10.1002/alz.13400. Epub 2023 Aug 3.
4
Plasma Biomarkers of Alzheimer's Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice.阿尔茨海默病的血浆生物标志物:现有检测方法、最新进展及对临床实践的意义综述
J Alzheimers Dis Rep. 2023 May 3;7(1):355-380. doi: 10.3233/ADR-230029. eCollection 2023.
5
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer's disease.神经炎症性脑脊液生物标志物 MIF、sTREM1 和 sTREM2 在阿尔茨海默病中表现出动态表达谱。
J Neuroinflammation. 2023 May 5;20(1):107. doi: 10.1186/s12974-023-02796-9.
6
Exercise suppresses neuroinflammation for alleviating Alzheimer's disease.运动抑制神经炎症,从而缓解阿尔茨海默病。
J Neuroinflammation. 2023 Mar 19;20(1):76. doi: 10.1186/s12974-023-02753-6.
7
Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction.运动改善认知功能障碍的分子机制研究进展。
Transl Neurodegener. 2023 Feb 27;12(1):9. doi: 10.1186/s40035-023-00341-5.
8
AD-associated CSF biomolecular changes are attenuated in KL-VS heterozygotes.与阿尔茨海默病相关的脑脊液生物分子变化在KL-VS杂合子中减弱。
Alzheimers Dement (Amst). 2022 Dec 7;14(1):e12383. doi: 10.1002/dad2.12383. eCollection 2022.
9
Cardiorespiratory fitness and cognition in persons at risk for Alzheimer's disease.阿尔茨海默病高危人群的心肺适能与认知
Alzheimers Dement (Amst). 2022 Jul 8;14(1):e12330. doi: 10.1002/dad2.12330. eCollection 2022.
10
Potential role of chitinase-3-like protein 1 (CHI3L1/YKL-40) in neurodegeneration and Alzheimer's disease.几丁质酶 3 样蛋白 1(CHI3L1/YKL-40)在神经退行性变和阿尔茨海默病中的潜在作用。
Alzheimers Dement. 2023 Jan;19(1):9-24. doi: 10.1002/alz.12612. Epub 2022 Mar 2.